Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Explore US market cap tilt retirement funds to adjust exposure. The intro covers when tilting helps and how to implement a balanced approach.
28,282 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
SpaceX launched an AI-focused IPO that stunned markets, with shares jumping 19% and a $2.2 trillion valuation. Analys...
Palantir has volatile days, but one wall street analyst believes the stock could double within a year. This article b...
A patient investor could see a multi-year rebound in a little-known robotics stock. Learn the growth drivers, how to ...
Analysts say SpaceX employees have amassed paper wealth that could, in theory, buy every home in a midsize Texas city...
SpaceX announces a year-long insider lockup with a 15-date unlock schedule to follow. The move tests liquidity expect...
A surge in crypto funding surging again accompanies a strategic pivot by major VCs toward infrastructure and tokenize...
Strategy reported a $12.54 billion Q1 loss driven by unrealized BTC declines, even as its software business expanded ...
Fox agreed to buy Roku for $22 billion, sending Roku stock to four-year highs and triggering debate over how the deal...
Memory markets are shifting as mega-capex from Hynix and Samsung could ease shortages. Here's what that means for Mic...
Tired of guessing what to charge for your Airbnb? This practical playbook shows you how to price with data, test stra...
The latest weekly data show the number people getting unemployment dropping to a 2½-year low, as initial claims ease ...